Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Shore

Showing results (401-410 of 590) with videos related to

Pageof 59
Sort By:
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 9, 2010
National trends in the management and survival of surgically managed gallbladder adenocarcinoma over 15 years: a population-based analysisSkye C Mayo, Andrew D Shore, Hari Nathan, et al.
Pediatric Pulmonology|April 1, 2024
Practices and perspectives on advanced diagnostic and interventional bronchoscopy among pediatric pulmonologists in the United StatesA Corcoran, D Shore, R P Boesch, et al.
Reviews in Urology|November 27, 2019
Preserving Independent Urology: LUGPA's First DecadeNeal D Shore, Deepak A Kapoor, Evan R Goldfischer, et al.
Urology|July 13, 2013
Does bariatric surgery affect urinary incontinence?Leise R Knoepp, Michelle J Semins, E James Wright, et al.
The Journal of Urology|April 10, 2018
The IMAAGEN Study: Effect of Abiraterone Acetate and Prednisone on Prostate Specific Antigen and Radiographic Disease Progression in Patients with Nonmetastatic Castration Resistant Prostate CancerCharles J Ryan, E David Crawford, Neal D Shore, et al.
The Journal of Urology|February 9, 2023
Nadir Prostate-specific Antigen as an Independent Predictor of Survival Outcomes: A Post Hoc Analysis of the PROSPER Randomized Clinical TrialMaha Hussain, Cora N Sternberg, Eleni Efstathiou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2016
Changes in Bone Turnover Marker Levels and Clinical Outcomes in Patients with Advanced Cancer and Bone Metastases Treated with Bone Antiresorptive AgentsAllan Lipton, Matthew R Smith, Karim Fizazi, et al.
Future Oncology (London, England)|August 16, 2023
Plain language summary: Can declines in prostate-specific antigen level indicate how long patients with advanced prostate cancer will live when treated with enzalutamide?Maha Hussain, Cora N Sternberg, Eleni Efstathiou, et al.
Obesity Surgery|January 25, 2012
Clinical outcomes after bariatric surgery: a five-year matched cohort analysis in seven US statesShari Danielle Bolen, Hsien-Yen Chang, Jonathan P Weiner, et al.
Cancer Chemotherapy and Pharmacology|July 4, 2012
Effect of abiraterone acetate plus prednisone on the QT interval in patients with metastatic castration-resistant prostate cancerA W Tolcher, K N Chi, N D Shore, et al.
Pageof 59

Showing results (401-410 of 590) with videos related to

Sort By:
Pageof 59
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 9, 2010
National trends in the management and survival of surgically managed gallbladder adenocarcinoma over 15 years: a population-based analysisSkye C Mayo, Andrew D Shore, Hari Nathan, et al.
Pediatric Pulmonology|April 1, 2024
Practices and perspectives on advanced diagnostic and interventional bronchoscopy among pediatric pulmonologists in the United StatesA Corcoran, D Shore, R P Boesch, et al.
Reviews in Urology|November 27, 2019
Preserving Independent Urology: LUGPA's First DecadeNeal D Shore, Deepak A Kapoor, Evan R Goldfischer, et al.
Urology|July 13, 2013
Does bariatric surgery affect urinary incontinence?Leise R Knoepp, Michelle J Semins, E James Wright, et al.
The Journal of Urology|April 10, 2018
The IMAAGEN Study: Effect of Abiraterone Acetate and Prednisone on Prostate Specific Antigen and Radiographic Disease Progression in Patients with Nonmetastatic Castration Resistant Prostate CancerCharles J Ryan, E David Crawford, Neal D Shore, et al.
The Journal of Urology|February 9, 2023
Nadir Prostate-specific Antigen as an Independent Predictor of Survival Outcomes: A Post Hoc Analysis of the PROSPER Randomized Clinical TrialMaha Hussain, Cora N Sternberg, Eleni Efstathiou, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2016
Changes in Bone Turnover Marker Levels and Clinical Outcomes in Patients with Advanced Cancer and Bone Metastases Treated with Bone Antiresorptive AgentsAllan Lipton, Matthew R Smith, Karim Fizazi, et al.
Future Oncology (London, England)|August 16, 2023
Plain language summary: Can declines in prostate-specific antigen level indicate how long patients with advanced prostate cancer will live when treated with enzalutamide?Maha Hussain, Cora N Sternberg, Eleni Efstathiou, et al.
Obesity Surgery|January 25, 2012
Clinical outcomes after bariatric surgery: a five-year matched cohort analysis in seven US statesShari Danielle Bolen, Hsien-Yen Chang, Jonathan P Weiner, et al.
Cancer Chemotherapy and Pharmacology|July 4, 2012
Effect of abiraterone acetate plus prednisone on the QT interval in patients with metastatic castration-resistant prostate cancerA W Tolcher, K N Chi, N D Shore, et al.
Pageof 59